 Treatment rheumatoid arthritis extracorporeal photochemotherapy pilot study pilot study patients rheumatoid arthritis treatment extracorporeal photoactivation inert methoxsalen ultraviolet energy form lymphocyte DNA injured cells patient Prior experimental studies regimen immune reaction antigens treated cells clinical trial patients cutaneous cell lymphoma successful current study patients successive days weeks therapy breakpoint joint counts joint scores patients patients measures mean baseline values variable improvement direct indicators clinical response joint counts scores fourth patient baselines alternative therapy study patients Mean joint counts different zero apparent breakpoint apparent responders entire group patients completion therapy delay months clinical deterioration patients mechanical adverse effect single episode transient hypotension treatment sessions toxic effects